Literature DB >> 32091651

It Is Time to Talk About Fertility and Immunotherapy.

Narjust Duma1, Matteo Lambertini2,3.   

Abstract

Entities:  

Keywords:  Gonadotoxicity; Immunotherapy; Infertility; Oncofertility

Mesh：

Year:  2020        PMID： 32091651      PMCID： PMC7160400          DOI： 10.1634/theoncologist.2019-0837

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  12 in total

1.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Kutluk Oktay; Brittany E Harvey; Ann H Partridge; Gwendolyn P Quinn; Joyce Reinecke; Hugh S Taylor; W Hamish Wallace; Erica T Wang; Alison W Loren
Journal:  J Clin Oncol       Date:  2018-04-05       Impact factor: 44.544

2.  Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.

Authors:  Alexander M M Eggermont; Christian U Blank; Mario Mandala; Georgina V Long; Victoria Atkinson; Stéphane Dalle; Andrew Haydon; Mikhail Lichinitser; Adnan Khattak; Matteo S Carlino; Shahneen Sandhu; James Larkin; Susana Puig; Paolo A Ascierto; Piotr Rutkowski; Dirk Schadendorf; Rutger Koornstra; Leonel Hernandez-Aya; Michele Maio; Alfonsus J M van den Eertwegh; Jean-Jacques Grob; Ralf Gutzmer; Rahima Jamal; Paul Lorigan; Nageatte Ibrahim; Sandrine Marreaud; Alexander C J van Akkooi; Stefan Suciu; Caroline Robert
Journal:  N Engl J Med       Date:  2018-04-15       Impact factor: 91.245

Review 3.  Thyroid dysfunctions secondary to cancer immunotherapy.

Authors:  P Chalan; G Di Dalmazi; F Pani; A De Remigis; A Corsello; P Caturegli
Journal:  J Endocrinol Invest       Date:  2017-12-13       Impact factor: 4.256

Review 4.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 5.  Developmental and reproductive toxicology studies in nonhuman primates.

Authors:  Gary J Chellman; Jeanine L Bussiere; Norbert Makori; Pauline L Martin; Yojiro Ooshima; Gerhard F Weinbauer
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2009-12

6.  Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.

Authors:  Patrizio Caturegli; Giulia Di Dalmazi; Martina Lombardi; Federica Grosso; H Benjamin Larman; Tatianna Larman; Giacomo Taverna; Mirco Cosottini; Isabella Lupi
Journal:  Am J Pathol       Date:  2016-10-15       Impact factor: 4.307

Review 7.  Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies.

Authors:  S Postel-Vinay; S Aspeslagh; E Lanoy; C Robert; J-C Soria; A Marabelle
Journal:  Ann Oncol       Date:  2015-11-16       Impact factor: 32.976

8.  Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration-approved systemic therapies.

Authors:  Jessica R Walter; Shuai Xu; Amy S Paller; Jennifer N Choi; Teresa K Woodruff
Journal:  J Am Acad Dermatol       Date:  2016-09       Impact factor: 11.527

9.  Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.

Authors:  Yucai Wang; Shouhao Zhou; Fang Yang; Xinyue Qi; Xin Wang; Xiaoxiang Guan; Chan Shen; Narjust Duma; Jesus Vera Aguilera; Ashish Chintakuntlawar; Katharine A Price; Julian R Molina; Lance C Pagliaro; Thorvardur R Halfdanarson; Axel Grothey; Svetomir N Markovic; Grzegorz S Nowakowski; Stephen M Ansell; Michael L Wang
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

Review 10.  A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.

Authors:  Petros Fessas; Hassal Lee; Shinji Ikemizu; Tobias Janowitz
Journal:  Semin Oncol       Date:  2017-07-04       Impact factor: 4.929
View more
  12 in total

1.  Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.

Authors:  Pauline C Xu; Yi Luan; Seok-Yeong Yu; Jing Xu; Donald W Coulter; So-Youn Kim
Journal:  J Endocrinol       Date:  2021-11-24       Impact factor: 4.286

2.  Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.

Authors:  Arjun Mittra; Abdul Rafeh Naqash; James H Murray; Shanda Finnigan; Joanne Kwak-Kim; S Percy Ivy; Alice P Chen; Elad Sharon
Journal:  Oncologist       Date:  2021-09-20       Impact factor: 5.837

3.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer.

Authors:  Leisha A Emens; Sylvia Adams; Ashley Cimino-Mathews; Mary L Disis; Margaret E Gatti-Mays; Alice Y Ho; Kevin Kalinsky; Heather L McArthur; Elizabeth A Mittendorf; Rita Nanda; David B Page; Hope S Rugo; Krista M Rubin; Hatem Soliman; Patricia A Spears; Sara M Tolaney; Jennifer K Litton
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 4.  Fertility preservation techniques in cervical carcinoma.

Authors:  Erica Silvestris; Angelo Virgilio Paradiso; Carla Minoia; Antonella Daniele; Gennaro Cormio; Raffaele Tinelli; Stella D'Oronzo; Paola Cafforio; Vera Loizzi; Miriam Dellino
Journal:  Medicine (Baltimore)       Date:  2022-04-29       Impact factor: 1.817

5.  Multidisciplinary consensus on the criteria for fertility preservation in cancer patients.

Authors:  A Santaballa; C Márquez-Vega; Á Rodríguez-Lescure; Á Rovirosa; L Vázquez; I Zeberio-Etxetxipia; M Andrés; L Bassas; E Ceballos-Garcia; J Domingo; D Manau-Trullas
Journal:  Clin Transl Oncol       Date:  2021-10-11       Impact factor: 3.405

Review 6.  Regulation of the innate immune cells during pregnancy: An immune checkpoint perspective.

Authors:  Wen-Xuan Li; Xiang-Hong Xu; Li-Ping Jin
Journal:  J Cell Mol Med       Date:  2021-10-28       Impact factor: 5.310

Review 7.  Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women.

Authors:  Valentino Martelli; Maria Maddalena Latocca; Tommaso Ruelle; Marta Perachino; Luca Arecco; Kristi Beshiri; Maria Grazia Razeti; Marco Tagliamento; Maurizio Cosso; Piero Fregatti; Matteo Lambertini
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-05-24

8.  Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.

Authors:  Wanyuan Cui; Prudence A Francis; Sherene Loi; Martha Hickey; Catharyn Stern; Lumine Na; Ann H Partridge; Sibylle Loibl; Richard A Anderson; Karla J Hutt; Louise A Keogh; Kelly-Anne Phillips
Journal:  J Natl Cancer Inst       Date:  2021-05-28       Impact factor: 11.816

9.  Knowledge of iatrogenic premature ovarian insufficiency among Chinese obstetricians and gynaecologists: a national questionnaire survey.

Authors:  Yanfang Wang; Ying Zou; Wei Wang; Qingmei Zheng; Ying Feng; Han Dong; Zhangyun Tan; Xiaoqin Zeng; Yinqing Zhao; Danhong Peng; Xiaomin Yang; Aijun Sun
Journal:  J Ovarian Res       Date:  2020-11-18       Impact factor: 4.234

10.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Authors:  Julie R Brahmer; Hamzah Abu-Sbeih; Paolo Antonio Ascierto; Jill Brufsky; Laura C Cappelli; Frank B Cortazar; David E Gerber; Lamya Hamad; Eric Hansen; Douglas B Johnson; Mario E Lacouture; Gregory A Masters; Jarushka Naidoo; Michele Nanni; Miguel-Angel Perales; Igor Puzanov; Bianca D Santomasso; Satish P Shanbhag; Rajeev Sharma; Dimitra Skondra; Jeffrey A Sosman; Michelle Turner; Marc S Ernstoff
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.